Table 1 Patient characteristics (n = 202)
Age (years), mean (SD) [range] | 66.9 (12.2) [20–94] |
|---|---|
Gender, n (%) | |
Women | 61 (30.2) |
Men | 141 (69.8) |
Type of atrial arrhythmia, n (%) | |
Arial fibrillation | 179 (88.6) |
Atrial flutter | 3 (1.5) |
Combination of atrial fibrillation and atrial flutter | 18 (8.9) |
Missing data | 2 (0.9) |
Treatment, n (%) | |
DC-conversion | 72 (35.6) |
Catheter ablation | 128 (63.3) |
Missing data | 2 (0.9) |
Medication, n (%) | |
Anti-coagulants | 187 (92.5) |
NOAC | 150 (74.3) |
Warfarin | 21 (10.4) |
Thrombocyte inhibitor | 16 (7.9) |
Anti-arrhythmics, n (%) | |
Beta blockers | 79 (39.6) |
Ca-channel blockers | 41 (20.3) |
Digoxin | 6 (3.0) |
Class Ic | 24 (11.9) |
Class III | 62 (30.7) |
Other medications, n (%) | |
Statins | 76 (37.6) |
ACE-inhibitors | 54 (26.7) |
AII-inhibitors | 74 (36.6) |